{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:01:27Z","timestamp":1761512487281},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.psychres.2007.05.008","type":"journal-article","created":{"date-parts":[[2007,12,26]],"date-time":"2007-12-26T16:24:34Z","timestamp":1198686274000},"page":"75-78","source":"Crossref","is-referenced-by-count":27,"title":["Plasma apolipoprotein E is decreased in schizophrenia spectrum and bipolar disorder"],"prefix":"10.1016","volume":"158","author":[{"given":"Brian","family":"Dean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Digney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suresh","family":"Sundram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Scarr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2007.05.008_bib16","series-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric Association","year":"1994"},{"key":"10.1016\/j.psychres.2007.05.008_bib1","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1172\/JCI109975","article-title":"Radioimmunoassay studies of human apolipoprotein E","volume":"66","author":"Blum","year":"1980","journal-title":"Journal of Clinical Investigation"},{"key":"10.1016\/j.psychres.2007.05.008_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1600-0447.2005.00522.x","article-title":"Valproate in bipolar disorder: 2000 onwards","volume":"426","author":"Bowden","year":"2005","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1016\/j.psychres.2007.05.008_bib3","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S0006-3223(03)00075-1","article-title":"Increased levels of apolipoprotein E in the frontal cortex of subjects with schizophrenia","volume":"54","author":"Dean","year":"2003","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.05.008_bib4","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.biopsych.2004.12.028","article-title":"Differential changes in apolipoprotein E in schizophrenia and bipolar I disorder","volume":"57","author":"Digney","year":"2005","journal-title":"Biological Psychiatry"},{"key":"10.1016\/j.psychres.2007.05.008_bib5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000092219","article-title":"Atypical antipsychotic usage-related higher serum leptin levels and disabled lipid profiles in euthymic bipolar patients","volume":"53","author":"Gergerlioglu","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.psychres.2007.05.008_bib6","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00000441-199430840-00002","article-title":"Hypocholesterolemia and affective disorders","volume":"308","author":"Glueck","year":"1994","journal-title":"American Journal of Medical Science"},{"key":"10.1016\/j.psychres.2007.05.008_bib7","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.schres.2005.05.001","article-title":"Serum lipid profiles and schizophrenia: effects of conventional or atypical antipsychotic drugs in Taiwan","volume":"80","author":"Huang","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2007.05.008_bib8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/BF01064966","article-title":"Positive-negative symptom assessment in schizophrenia: psychometric issues and scale comparison","volume":"61","author":"Kay","year":"1990","journal-title":"Psychiatric Quarterly"},{"key":"10.1016\/j.psychres.2007.05.008_bib9","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1046\/j.1471-4159.2003.01866.x","article-title":"Antipsychotic drugs differentially modulate apolipoprotein D in rat brain","volume":"86","author":"Khan","year":"2003","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.psychres.2007.05.008_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0920-9964(01)00378-4","article-title":"Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome","volume":"58","author":"Mahadik","year":"2002","journal-title":"Schizophrenia Research"},{"key":"10.1016\/j.psychres.2007.05.008_bib11","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1046\/j.1471-4159.2001.00027.x","article-title":"Clozapine increases apolipoprotein D expression in rodent brain: towards a mechanism for neuroleptic pharmacotherapy","volume":"76","author":"Thomas","year":"2001","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.psychres.2007.05.008_bib12","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1073\/pnas.071056198","article-title":"Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders","volume":"98","author":"Thomas","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.psychres.2007.05.008_bib13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.mp.4001223","article-title":"Differences in neuroanatomical sites of apoD elevation discriminate between schizophrenia and bipolar disorder","volume":"8","author":"Thomas","year":"2003","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.psychres.2007.05.008_bib14","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.mp.4001425","article-title":"Antipsychotic drug treatment alters expression of mRNAs encoding lipid metabolism-related proteins","volume":"8","author":"Thomas","year":"2003","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.psychres.2007.05.008_bib15","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"British Journal of Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178107001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178107001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,2]],"date-time":"2019-01-02T01:54:26Z","timestamp":1546394066000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178107001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S0165178107001576"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2007.05.008","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}